Detection and Analysis of Gene Mutations in Patients with Fibrinogen Deficiency by Next Generation Sequencing
ISTH Academy. Sun B. Jul 10, 2019; 274085; OC 74.5
Boyang Sun
Boyang Sun
Access to Reserved content is available to attendees of the Congress until the end of the year and always available for full ISTH members.

Click here to join ISTH or renew your membership.

Discussion Forum (0)
Rate & Comment (0)

OC 74.5

Detection and Analysis of Gene Mutations in Patients with Fibrinogen Deficiency by Next Generation Sequencing

X. Zhang1, D. Zhang2, B. Sun2, F. Zhou1
1Zhongnan Hospital of Wuhan University, Wuhan, China, 2Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Main Topic: Fibrinolysis and Proteolysis
Category: Fibrinogen & Factor XIII

Background: Fibrinogen deficiency can be quantitative (afibrinogenemia, hypofibrinogenemia) or functional (dysfibrinognemia). Congenital fibrinogen disorders can lead to the development of bleeding or thromboembolic events. When striving for applicability in routine clinical practice, it soon becomes clear that population Sanger sequencing is too labor-intensive and time-consuming.
Aims: In this study, we aimed to assess FGA, FGB, FGG gene mutations through next generation sequencing (NGS) in diagnosed patients of Fibrinogen deficiency.
Methods: A cohort of 19 patients with clinical symptoms who underwent laboratory were enrolled for molecular genetic analysis by NGS. Sample DNA was amplified using Ampliseq primer panel, and libraries were prepared following the manufacturer´s Ion Ampliseq Library Preparation protocol. Individual samples were barcoded, pooled, templated, and sequenced on the Ion Torrent Proton Sequencer. Raw sequencing reads generated by the Ion Torrent sequencer were quality and adaptor trimmed by Ion Torrent Suite and then aligned to the hg19 reference sequence.
Results: We identified 16 pathogenic mutations, including 9 novel mutations, from all the 19 patients. Amon those mutations, mutations in FGA genes were p.L506fs, p.G36S, p.R743Q, p.M11T, p.R38G, p.L28P, p.R35C and p.R35H; mutations in FGB gene were p.N190fs and p.R285C; mutations in FGG gene were p.D167G, p.R301H, p.N351D, p.C365G, p.S404F, p.R301C. Compound heterozygous mutations were identified in 2 patients, 1 patients with FGA: p.R743Q and p.M11T, and 1 patient with FGB: p.N190fs and p.R285C.
Conclusions: NGS technology is systematic and efficient, and may be a useful method to detect the mutations in Fibrinogen deficiency patients.

Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings